ARMISTICE CAPITAL LLC 13D and 13G filings for EyeGate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:27 pm Purchase | 2021-12-31 | 13G | EyeGate Pharmaceuticals, Inc. EYEG | ARMISTICE CAPITAL LLC | 723,000 5.400% | 723,000 (New Position) | Filing |
| 2021-08-13 4:01 pm Unchanged | 2021-08-13 | 13G | EyeGate Pharmaceuticals, Inc. EYEG | ARMISTICE CAPITAL LLC | 2,916,101 19.800% | 0 (Unchanged) | Filing |
| 2021-08-03 5:04 pm Sale | 2021-07-27 | 13D | EyeGate Pharmaceuticals, Inc. EYEG | ARMISTICE CAPITAL LLC | 2,916,101 28.900% | -1,883,000 (-39.24%) | Filing |
| 2021-01-12 5:08 pm Purchase | 2021-01-06 | 13D | EyeGate Pharmaceuticals, Inc. EYEG | ARMISTICE CAPITAL LLC | 4,799,101 56.200% | 1,554,101 (+47.89%) | Filing |